These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7526693)

  • 1. Mallory body filaments become insoluble after normal assembly into intermediate filaments.
    Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C
    Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides.
    Franke WW; Denk H; Schmid E; Osborn M; Weber K
    Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay.
    Kachi K; Cadrin M; French SW
    Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cytokeratin intermediate filaments by calcium-activated proteases (calpains) in vitro: implications for formation of Mallory bodies.
    Makowski GS; Ramsby ML
    Res Commun Mol Pathol Pharmacol; 1998 Sep; 101(3):211-23. PubMed ID: 9874279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
    Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW
    Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mallory body as an aggresome: in vitro studies.
    Riley NE; Li J; Worrall S; Rothnagel JA; Swagell C; van Leeuwen FW; French SW
    Exp Mol Pathol; 2002 Feb; 72(1):17-23. PubMed ID: 11784119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
    Zatloukal K; Böck G; Rainer I; Denk H; Weber K
    Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies.
    Preisegger KH; Zatloukal K; Spurej G; Denk H
    Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice.
    Irie T; Benson NC; French SW
    Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mallory body (cytokeratin aggresomes) formation is prevented in vitro by p38 inhibitor.
    Nan L; Dedes J; French BA; Bardag-Gorce F; Li J; Wu Y; French SW
    Exp Mol Pathol; 2006 Jun; 80(3):228-40. PubMed ID: 16563375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin-containing inclusions affect cell morphology and distribution of cytosolic cellular components.
    Hanada S; Harada M; Kumemura H; Omary MB; Kawaguchi T; Taniguchi E; Koga H; Yoshida T; Maeyama M; Baba S; Ueno T; Sata M
    Exp Cell Res; 2005 Apr; 304(2):471-82. PubMed ID: 15748892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.
    Yuan QX; Nagao Y; Gaal K; Hu B; French SW
    Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.
    Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H
    Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes.
    Irie T; Benson NC; French SW
    Lab Invest; 1984 Mar; 50(3):303-12. PubMed ID: 6199585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight component of Mallory bodies detected by a monoclonal antibody.
    Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW
    Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H; Marceau N; French SW
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study.
    Okanoue T; Ohta M; Ou O; Kachi K; Kagawa K; Yuki T; Okuno T; Takino T; French SW
    Lab Invest; 1985 Nov; 53(5):534-40. PubMed ID: 2414564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody.
    Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL
    Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.